Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoogervorst, E. M.
Right arrow Articles by de Vries, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoogervorst, E. M.
Right arrow Articles by de Vries, A.
[Cancer Research 65, 3610-3616, May 1, 2005]
© 2005 American Association for Cancer Research


Molecular Biology, Pathobiology, and Genetics

Lack of p53 Ser389 Phosphorylation Predisposes Mice to Develop 2-Acetylaminofluorene–Induced Bladder Tumors but not Ionizing Radiation–Induced Lymphomas

Esther M. Hoogervorst1, Wendy Bruins1, Edwin Zwart1, Conny Th.M. van Oostrom1, Gerard J. van den Aardweg2, Rudolf B. Beems1, Jolanda van den Berg1, Tyler Jacks3, Harry van Steeg1 and Annemieke de Vries1

1 National Institute of Public Health and the Environment, Laboratory of Toxicology, Pathology, and Genetics, Bilthoven; 2 Josephine Nefkens Institute, Erasmus MC, Rotterdam, the Netherlands; and 3 Center for Cancer Research, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts

Requests for reprints: Annemieke de Vries, National Institute of Public Health and the Environment, Laboratory of Toxicology, Pathology, and Genetics, 3720 BA Bilthoven, the Netherlands. Phone: 31-30-274-3483; Fax: 31-30-274-4446; E-mail: Annemieke.de.Vries{at}rivm.nl.

Cellular activity of the tumor suppressor protein p53 is primarily regulated by posttranslational modifications. Phosphorylation of the COOH terminus, including Ser389, is thought to result in a conformational change of the p53 protein, enhancing DNA binding and transcriptional activity. In vitro studies presented here show that, in addition to UV radiation, Ser389 is phosphorylated upon exposure to 2-acetylaminofluorene (2-AAF). Both agents induce bulky DNA adducts repaired by nucleotide excision repair (NER). In contrast, ionizing radiation, known to induce DNA damage not repaired by NER, does not result in Ser389 phosphorylation. Previously, we have shown that p53.S389A mutant mice, lacking the Ser389 phosphorylation site, are sensitive to developing UV-induced skin tumors. Here, we show that p53.S389A mice are also prone to developing 2-AAF–induced urinary bladder tumors, whereas no increased tumor response was found upon ionizing irradiation. These results provide evidence for our hypothesis that phosphorylation of Ser389 is important for activation of p53 to exert its function as a tumor suppressor not exclusively upon the presence of UV-induced DNA damage, but also upon exposure to other bulky adduct-inducing agents. Analysis of 2-AAF– and UV-induced tumors from p53.S389A mice revealed the presence of additional p53 mutations, indicating that lack of Ser389 phosphorylation by itself is not sufficient to abrogate p53 function in tumor suppression. In addition, analyses of skin tumors of p53.S389A mice revealed an interesting hotspot mutation previously found exclusively in NER-deficient mice and patients.




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
W. Bruins, O. Bruning, M. J. Jonker, E. Zwart, T. V. van der Hoeven, J. L. A. Pennings, H. Rauwerda, A. de Vries, and T. M. Breit
The Absence of Ser389 Phosphorylation in p53 Affects the Basal Gene Expression Level of Many p53-Dependent Genes and Alters the Biphasic Response to UV Exposure in Mouse Embryonic Fibroblasts
Mol. Cell. Biol., March 15, 2008; 28(6): 1974 - 1987.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
B. Oster, B. Bundgaard, T. R. Hupp, and P. Hollsberg
Human herpesvirus 6B induces phosphorylation of p53 in its regulatory domain by a CK2- and p38-independent pathway
J. Gen. Virol., January 1, 2008; 89(1): 87 - 96.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
W. Bruins, M. J. Jonker, O. Bruning, J. L.A. Pennings, M. M. Schaap, E. M. Hoogervorst, H. van Steeg, T. M. Breit, and A. de Vries
Delayed expression of apoptotic and cell-cycle control genes in carcinogen-exposed bladders of mice lacking p53.S389 phosphorylation
Carcinogenesis, August 1, 2007; 28(8): 1814 - 1823.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. W.P. Wijnhoven, E. N. Speksnijder, X. Liu, E. Zwart, C. Th. M. vanOostrom, R. B. Beems, E. M. Hoogervorst, M. M. Schaap, L. D. Attardi, T. Jacks, et al.
Dominant-Negative but not Gain-of-Function Effects of a p53.R270H Mutation in Mouse Epithelium Tissue after DNA Damage
Cancer Res., May 15, 2007; 67(10): 4648 - 4656.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
O. Moiseeva, F. A. Mallette, U. K. Mukhopadhyay, A. Moores, and G. Ferbeyre
DNA Damage Signaling and p53-dependent Senescence after Prolonged beta-Interferon Stimulation
Mol. Biol. Cell, April 1, 2006; 17(4): 1583 - 1592.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.